COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Valuation Ratios Analysis including PE, PB, PS, EV/EBITDA. Analyze if 3349.T stock is undervalued compared to peers/competitors, industry and sector standards or based on Value Investing Principles.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T Valuation Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.

Price-to-Earnings Ratio (P/E)

22.44

Increased from previous period

P/E 20-25 - Speculative pricing. Jesse Livermore would caution about crowd psychology at these levels. Essential to verify Earnings Growth trends.

Price-to-Sales Ratio (P/S)

2.82

Increased from previous period

P/S 2.0-3.0 - Fair value range. Philip Fisher would examine if premium margins or growth justify this multiple. Verify competitive position.

Price-to-Book Ratio (P/B)

2.98

Increased from previous period

P/B 2.0-3.0 - Premium territory. Seth Klarman would demand clear evidence of understated assets or superior economics.

Price-to-Free Cash Flow Ratio

72.51

P/FCF above 30 - Expensive zone. Benjamin Graham would question if any business can justify such a premium to free cash flow.

Price-to-Operating Cash Flow Ratio

72.51

P/OCF above 25 - Expensive zone. Benjamin Graham would question if any business deserves such a premium to operating cash flow.

Price-to-Fair Value

2.98

Increased from previous period

Price above 140% of fair value - Danger zone. Philip Fisher would require extraordinary growth evidence. Scrutinize all valuation inputs carefully.

Earnings Yield

1.11%

Decreased from previous period

Earnings yield below 3% - Danger zone. Philip Fisher would require extraordinary growth evidence. Examine all growth and quality metrics.

Free Cash Flow Yield

1.38%

FCF yield below 3% - Danger zone. Philip Fisher would require extraordinary growth evidence. Examine all capital allocation metrics.

Select Chart Metric:

3349.T Valuation Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Price-to-Earnings Ratio (P/E)

22.44

Increased from previous period

P/E 20-25 - Speculative pricing. Jesse Livermore would caution about crowd psychology at these levels. Essential to verify Earnings Growth trends.

Price-to-Sales Ratio (P/S)

2.82

Increased from previous period

P/S 2.0-3.0 - Fair value range. Philip Fisher would examine if premium margins or growth justify this multiple. Verify competitive position.

Price-to-Book Ratio (P/B)

2.98

Increased from previous period

P/B 2.0-3.0 - Premium territory. Seth Klarman would demand clear evidence of understated assets or superior economics.

Price-to-Free Cash Flow Ratio

72.51

P/FCF above 30 - Expensive zone. Benjamin Graham would question if any business can justify such a premium to free cash flow.

Price-to-Operating Cash Flow Ratio

72.51

P/OCF above 25 - Expensive zone. Benjamin Graham would question if any business deserves such a premium to operating cash flow.

Price-to-Fair Value

2.98

Increased from previous period

Price above 140% of fair value - Danger zone. Philip Fisher would require extraordinary growth evidence. Scrutinize all valuation inputs carefully.

Earnings Yield

1.11%

Decreased from previous period

Earnings yield below 3% - Danger zone. Philip Fisher would require extraordinary growth evidence. Examine all growth and quality metrics.

Free Cash Flow Yield

1.38%

FCF yield below 3% - Danger zone. Philip Fisher would require extraordinary growth evidence. Examine all capital allocation metrics.

Select Chart Metric: